Sozialstiftung Bamberg
Sozialstiftung Bamberg
Bamberg, Bavaria, Germany5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Wild Blueberries in Colitis | Crohn disease, Digestive System Diseases, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Not applicable | 2026-10-01 | NCT06698601 | |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2026-04-21 | NCT03188874 | |
| Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, metabolic dysfunction-associated steatohepatitis, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not applicable | 2026-02-18 | NCT07417683 | |
| Impact of Diet and Lifestyle Modification on the Intestinal Barrier Integrity in Crohn's Disease | Crohn disease, Digestive System Diseases, colonic disorder, digestive system disorder, functional colonic disease, gastroenteritis, inflammatory bowel disease, intestinal disorder, irritable bowel syndrome | Recruiting | Not applicable | 2024-12-16 | NCT06719778 | |
| Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 3 | 2023-05-06 | NCT03948035 |